DISTRIBUTION OF PATIENTS INTO GROUPS DEPENDING ON THE SEVERITY OF CHF
Abstract
Chronicheartfailure(CHF)isoneof the mostsignificantproblems of modernhealthcare,causinghighmorbidity,frequency of hospitalizationsandmortalityamong the adultpopulation.According to the WorldHealthOrganization(WHO)andrecentepidemiologicalstudies, the prevalence of CHFin the worldrangesfrom1to3%amongadultsandincreasesto10-15%amongpeopleover70years of age.Despitesignificantprogressintherapy, the prevalenceandmortalityinCHFremainconsistentlyhigh,whichindicatestheneed to improveearlydiagnosisandpreventionmethods.
References
1.World Health Organization. Cardiovascular diseases. Fact sheet. 2023. – [Электронный ресурс]. – Режим доступа: https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds) (дата обращения: 01.07.2025).
2.Savarese G., Becher P.M., Lund L.H. The changing epidemiology of heart failure: unmet needs and future directions // The Lancet. – 2023. – Vol. 401, № 10375. – P. 1677–1690. – [Электронный ресурс]. – Режим доступа: https://doi.org/10.1016/S0140-6736(23)00437-2.
3.Yancy C.W. et al. 2017 ACC/AHA/HFSA Focused Update of the 2013 Heart Failure Guideline // J. Am. Coll. Cardiol. – 2017. – Vol. 70, № 6. – P. 776–803.
4.Bozkurt B. et al. Universal Definition and Classification of Heart Failure: A Consensus Statement // Eur. J. Heart Fail. – 2021. – Vol. 23, № 3. – P. 352–380.
5.Komajda M., Lam C.S.P. Heart failure with preserved ejection fraction: a clinical dilemma // Eur. Heart J. – 2020. – Vol. 41, № 23. – P. 2041–2047.
6.Cleland J.G.F. et al. Management of heart failure with preserved ejection fraction: international position statement // Eur. J. Heart Fail. – 2021. – Vol. 23, № 10. – P. 1576–1594.
7.McDonagh T.A. et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure // Eur. Heart J. – 2021. – Vol. 42, № 36. – P. 3599–3726. – [Электронный ресурс]. – Режим доступа: https://doi.org/10.1093/eurheartj/ehab368
8.Heidenreich P.A. et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure // Circulation. – 2022. – Vol. 145, № 18. – P. e895–e1032.
9.Pieske B. et al. How to diagnose heart failure with preserved ejection fraction: the HFA–PEFF diagnostic algorithm // Eur. Heart J. – 2019. – Vol. 40, № 40. – P. 3297–3317.
10.Lam C.S., Solomon S.D. The Middle Road in Heart Failure With Preserved Ejection Fraction // J. Am. Coll. Cardiol. – 2020. – Vol. 75, № 2. – P. 175–178.
11.Yamamoto N. et al. Utility of Non-Invasive Cardiac System (NICaS) in evaluating hemodynamic parameters in heart failure patients // J. Clin. Monit. Comput. – 2022. – Vol. 36, № 5. – P. 1203–1211.
12.Burkhoff D., Tyberg J.V. Hemodynamics of heart failure // Cardiol. Clin. – 2014. – Vol. 32, № 1. – P. 1–17.
13.Bayés-Genís A., Lupón J. et al. Use of NT-proBNP in clinical practice // Eur. Heart J. – 2016. – Vol. 37, № 30. – P. 2530–2535.
14.Dokainish H. et al. Incremental value of BNP and tissue Doppler echocardiography in the diagnosis of diastolic heart failure // Am. J. Cardiol. – 2011. – Vol. 107, № 5. – P. 757–761.
15.Ziaeian B., Fonarow G.C. Epidemiology and aetiology of heart failure // Nat. Rev. Cardiol. – 2022. – Vol. 19, № 5. – P. 339–352. – [Электронный ресурс]. – Режим доступа: https://doi.org/10.1038/s41569-021-00626-6
16.Vaduganathan M. et al. Global burden of heart failure: implications for prevention and management // J. Am. Coll. Cardiol. – 2020. – Vol. 76, № 17. – P. 1747–1760.
17.Ponikowski P. et al. Heart failure after myocardial infarction // Eur. J. Heart Fail. – 2020. – Vol. 22, № 9. – P. 1641–1652.
18.Lang R.M. et al. Recommendations for cardiac chamber quantification by echocardiography // Eur. Heart J. Cardiovasc. Imaging. – 2015. – Vol. 16, № 3. – P. 233–271.
19.Williams B. et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension // Eur. Heart J. – 2018. – Vol. 39, № 33. – P. 3021–3104.
